NORGES BANK - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,768,979
-39.2%
3,125,259
+7.7%
0.00%0.0%
Q3 2022$4,555,328
-21.9%
2,901,4830.0%0.00%
-50.0%
Q2 2022$5,831,981
+14.6%
2,901,483
+32.9%
0.00%
+100.0%
Q1 2022$5,087,748
+17.9%
2,183,583
+135.2%
0.00%0.0%
Q4 2021$4,317,000
-20.6%
928,292
+30.3%
0.00%0.0%
Q3 2021$5,437,000712,5350.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders